Atherosclerosis
Volume 195, Issue 2 , Pages 242-247 , December 2007

Wine, research and cardiovascular disease: Instructions for use

  • Alberto A.E. Bertelli

      Affiliations

    • Corresponding Author InformationCorrespondence address: Alberto Bertelli, MD, PhD, Dipartimento di Morfologia Umana, Università degli Studi di Milano, Via Mangiagalli, 31, 20133 Milano, Italy. Tel.: +39 0250315384; fax: +39 0250315387.

Received 1 February 2007 ,Revised 19 March 2007 ,Accepted 10 April 2007.

References 

  1. Naissaides M, Mamo JCL, James AP, Pal S. The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. Atherosclerosis. 2006;185:438–445
  2. Norata GD, Marchesi P, Passamonti S, et al. Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis. 2007;191:265–271
  3. Blanco-Colio LM, Muñoz-García B, Martín-Ventura JL, et al. Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet. Atherosclerosis. 2007;192:335–341
  4. Pignatelli P, Ghiselli A, Buchetti B, et al. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis. 2006;188:77–83
  5. Waterhouse AL. Wine Phenolics. Ann N Y Acad Sci. 2002;957:21–36
  6. Ruidavets JB, Teissedre PL, Ferrières J, Carando S, Bougard G, Cabanis JC. Catechin in the Mediterranean diet: vegetable, fruit or wine?. Atherosclerosis. 2000;153:107–117
  7. Arts ICW, Hollman PCH, Feskens EJM, Bas Bueno de Mesquita H, Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr. 2001;74:227–232
  8. Knekt P, Kumpulainen J, Järvinen R, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76:560–568
  9. Shishodia S, Aggarawal BB, Resveratrol, a polyphenol for all seasons In: Resveratrol in health, Disease, CRC Press, 2006, pp. 1–15.
  10. Tokusoglu Özlem, Ünal MK, Yemis F. Determination of the phytoalexin resveratrol (3,5,4′-trihydroxystilbene) in peanuts and pistachios by high-performance liquid chromatographic diode array (HPLC-DAD) and gas chromatography-mass spectrometry (GC–MS). J Agric Food Chem. 2005;53:5003–5009
  11. Wang Y, Catana F, Yang Y, Roderick R, van Breemen RB. An LC–MS method for analyzing total resveratrol in grape juice, cranberry juice and in wine. J Agric Food Chem. 2002;50:431–435
  12. Meng X, Maliakal P, Lu H, Lee MJ, Yang CS. Urinary and plasma levels of resveratrol and quercetin in humans, mice and rats after ingestion of pure compounds and grape juice. J Agric Food Chem. 2004;52:935–942
  13. Lamuela-Raventós RM, Waterhouse AL. Occurrence of resveratrol in selected California wines by a new HPLC method. J Agric Food Chem. 1993;41:521–523
  14. Chu Q, O’Dwyer M, Zeece MG. Direct analysis of resveratrol in wine by Micel capillary electrophoresis. J Agric Food Chem. 1998;46:509–513
  15. Mattivi F. Solid phase extraction of trans-resveratrol form wines for HPLC analysis. Z Lebensm Unters Forsch. 1993;196:522–525
  16. Goldberg DM, Karumanchiri A, Ng E, et al. Direct gas chromatographic-mass spectrometric method to assay cis-resveratrol in wines: preliminary survey of its concentration in commercial wines. J Agric Food Chem. 1995;43:1245–1250
  17. Jeandet P, Bessis R, Maume BF, Meunier P, Peyron D, Trollat P. Effect of enological practices on the resveratrol isomer content of wine. J Agric Food Chem. 1995;43:316–319
  18. Vrhovsek U, Wendelin S, Eder R. Effects of various vinification techniques on the concentration of cis-and trans-resveratrol and resveratrol glucoside isomers in wine. Am J Enol Vitic. 1997;48:214–219
  19. Corder R, Mullen W, Khan NQ, et al. Red wine procyanidins and vascular health. Nature. 2006;444:566
  20. Muller CJ, Fugelsang KC. Red wine but not white: the importance of fully characterizing wines used in health studies. Am J Clin Nutr. 1997;66:447–451
  21. Kroon PA, Clifford MN, Crozier A, et al. How should we assess the effects of exposure to dietary polyphenols in vitro?. Am J Clin Nutr. 2004;80:15–21
  22. Bertelli AAE. Pharmacokinetics and metabolism of resveratrol. In: Resveratrol in health and Disease, CRC Press, 2006, pp. 631–647.
  23. Horn TL, Cwik MJ, Morrissey RL, et al. Oncogenicity evaluation of resveratrol in p53 knockout mice. Food Chem Toxicol. 2007;45:55–63
  24. Goldberg DM, Yan J, Soleas GJ. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem. 2003;36:79–87
  25. Bertelli AAE, Giovannini L, Stradi R, Bertelli A, Tillement JP. Plasma, urine and tissue levels of trans-a and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue Reac. 1996;18:67–71
  26. Ferrero ME, Bertelli AAE, Fulgenzi A, et al. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr. 1998;68:1208–1214
  27. Teel RW, Huynh H. Modulation by phytochemicals of cytochrome P450-linked enzyme activity. Cancer Lett. 1998;133:135–141
  28. Leikert JF, Räthel TR, Wohlfart P, et al. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106:1614–1617
  29. Gu J, Wang CQ, Fan HH, et al. Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats. J Cardiovasc Pharmacol. 2006;47:711–721
  30. Zini R, Morin C, Bertelli A, Bertelli AAE, Tillement JP. Resveratrol-induced limitation of dysfunction of mitochondria isolated from rat brain in an anoxia-reoxygenation model. Life Sci. 2002;71:3091–3108
  31. Bertelli AAE, Giovannini L, De Caterina R, et al. Antiplatelet activity of cis-resveratrol. Drugs Exptl Cin Res. 1996;22:61–63
  32. Dobrydneva Y, Williams RL, Blackmore PF. Trans-resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Br J Pharmacol. 1999;128:149–157
  33. Liew R, Stagg MA, Macleod KT, Collins P. The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes. Eur J Pharmacol. 2005;519:1–8
  34. Zhang Y, Liu Y, Wang T, et al. Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem Biophys Res Commun. 2006;340:1192–1199
  35. Plin C, Tillement JP, Berdeaux A, Morin D. Resveratrol protects against cold ischemia—warm rexoxygenation-induced damages to mitochondria and cells in rat liver. Eur J Pharmacol. 2005;528:162–168
  36. Bråkenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB, Published online June 8, 2001.
  37. Pellegatta F, Bertelli AAE, Staels B, et al. Different short- and long-term effects of resveratrol on nuclear factor-kB phosphorylation and nuclear appearance in human endothelial cells. Am J Clin Nutr. 2003;77:1220–1228
  38. Shen F, Chen SJ, Dong XJ, et al. Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells. J Asian Nat Prod Res. 2003;5:151–157
  39. Cignarella A, Minici C, Bolego C, et al. Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats. Nutr metab Cardiovasc Dis. 2006;16:322–329
  40. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet. 1992;339:1523–1526
  41. Bertelli AAE, Giovannini L, Giannessi D, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue Reac. 1995;17:1–3
  42. De Santi C, Pietrabissa A, Spisni R, Mosca F, Pacifici GM. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica. 2000;30:609–617
  43. De Santi C, Pietrabissa A, Mosca F, Pacifici GM. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica. 2000;30:1047–1054
  44. Romero-Pérez AI, Lamuela-Raventós RM, Waterhouse AL, de la Torre-Boronat MC. Levels of cis- and trans-resveratrol and their glucosides in white and Rosé Vitis vinifera wines from Spain. J Agric Food Chem. 1996;44:2124–2128
  45. Chamkha M, Cathala B, Cheynier V, Douillard R. Phenolic composition of champagnes from Cardonnay and Pinot Noir Vintages. J Agric Food Chem. 2003;51:3179–3184
  46. El-Mohsen MA, Bayele H, Kuhnle G, et al. Distribution of [3H]trans-resveratrol in rat tissues following oral administration. Brit J Nutr. 2006;96:62–70
  47. Urpí-Sardà M, Jáuregui O, Lamuela-Raventós RM, et al. Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal Chem. 2005;77:3149–3155
  48. Jannin B, Menzel M, Berlot JP, et al. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem Pharmacol. 2004;68:1113–1118
  49. de la Torre R, Covas MI, Pujadas MA, Fitó M, Farré M. Is dopamine behind the health benefits of red wine?. Eur J Nutr. 2006;45:307–310
  50. Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425:191–196
  51. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337–342
  52. Kaeberlein M, McDonagh T, Heltweg B, et al. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem. 2005;280:17038–17045
  53. Zini R, Morin C, Bertelli A, Bertelli AAE, Tillement JP. Effrects of resveratrol on the rat brain respiratory chain. Drugs Exptl Clin Res. 1999;25:87–97
  54. Klatsky AL, Friedman GD, Armstrong MA, Kipp H. Wine, liquor, beer and mortality. Am J Epidemiol. 2003;158:585–595
  55. Whelan AP, Sutherland WHF, McCormick MP, et al. Effects of white and red wine on endothelial function in subjects with coronary artery disease.. Intern Med J. 2004;34:224–228
  56. Williams MJA, Sutherland WHF, Whelan AP, McCormick MP, de Jong SA. Acute effect of drinking red and white wines on circulating levels of inflammation-sensitive molecules in men with coronary artery disease. Metabolism. 2004;53:318–323
  57. Kikura M, lvey JH, Safon RA, Lee MK, Szlam F. The influence of red wine or white wine intake on platelet function and viscoelastic property of blood in volunteers. Platelets. 2004;15:37–41
  58. Daher CF, Slaiby R, Haddad N, Boustany K, Baroody GM. Effect of acute and chronic moderate red or white wine consumption on fasted and postprandial lipemia in the rat. J Toxicol Environ Health. 2006;69:1117–1131
  59. Bertelli AAE. Beneficial components of white wine. In:  Preedy VR,  Watson RR editor. Comprehensive handbook of alcohol related pathology. Elsevier; 2005;p. 389–392
  60. Caccetta RAA, Croft KD, Beilin LJ, Puddey IB. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr. 2000;71:67–74
  61. Bertelli A, Migliori M, Bertelli AAE, et al. Effect of some white wine phenols in preventing inflammatory cytokine release. Drugs Exptl Clin Res. 2002;28:11–15
  62. Betés-Saura C, Lacueva CA, Lamuela-Raventós RM. Phenolics in white free run juices and wines from Penedès by high-performance liquid chromatography: changes during vinification. J Agric Food Chem. 1996;3040–3046
  63. Bertelli AAE, Migliori M, Panichi V, et al. Oxidative stress and inflammatory reaction modulation by white wine. Ann N Y Acad Sci. 2002;957:295–301
  64. Di Tommaso D, Calabrese R, Rotilio D. Identification and quantitation of hydroxytyrosol in Italian Wines. J High Resol Chromatogr. 1998;21:549–553
  65. Wiseman SA, Mathot JN, de Fouw NJ, Tijburg LB. Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits. Atherosclerosis. 1996;120:15–23
  66. Covas MI, de la Torre K, Albadejo MF, et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Rad Biology Med. 2006;46:608–616
  67. Covas MI, Nyyssonen K, Poulsen HE, et al. for the EUROLIVE study group The effect of poplyphenols in olive oil on heart disease risk factors. A randomized trial. Ann Intern Med. 2006;145:333–341
  68. Bertelli AAE. Stockpiling of raw material for oseltamivir is not justified. BMJ. 2006;332:178
  69. Bianco A, Brufani M, Manna F, Melchioni C. Synthesis of a carbocyclic sialic acid analogue for the inhibition of influenza virus neuraminidase. Carbohydrate Res. 2001;332:23–31
  70. Nielsen NB, Schnohr P, Jensen G, Gronbaek M. Is the relationship between type of alcohol and mortality influenced by socio-economic status?. J Intern Med. 2004;255:280–288
  71. Barefoot JC, Gronboek M, Feaganes JR, McPherson RS, Williams RB, Siegler IC. Alcoholic beverage preference, diet, and health habits in the UNC Alumni Heart Study. Am J Clin Nutr. 2002;76:466–472
  72. Wannamethee SG, Camargo CA, Manson JE, Willett WC, Rimm EB. Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Arch Intern Med. 2003;163:1329–1336
  73. Stender S, Dyerberg J, Astrup A. High levels of industrially produced trans fat in popular fast foods. N Engl J Med. 2006;354:1650–1652
  74. Lesschaeve I, Noble AC. Polyphenols: factors influencing their sensory properties and their effects on food and beverage preferences. Am J Clin Nutr. 2005;81(suppl):330S–335S
  75. Mukamal KJ, Cushman M, Mittleman MA, Tracy R, Siscovick DS. Alcohol consumption and inflammatory markers in older adults: the cardiovascular health study. Atherosclerosis. 2004;173:79–87
  76. Mukamal KJ, Conigrave KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003;348:109–118
  77. Marques-Vidal P, Montaye M, Haas B, et al. Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME study. Atherosclerosis. 2001;157:431–440
  78. Estruch R, Sacanella E, Badia E, et al. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis. 2004;175:117–123
  79. The World Health Report 2002 page 66.
  80. Cardiovascular disease risk factors: new areas for research. Report of a WHO scientific group, WHO Technical Report Series 841. Page 23, WHO, Geneva, 1994.

PII: S0021-9150(07)00244-4

doi: 10.1016/j.atherosclerosis.2007.04.006

Atherosclerosis
Volume 195, Issue 2 , Pages 242-247 , December 2007

Article Tools